May 27, 2020
MEI Pharma to Present at the Jefferies Virtual Healthcare Conference
May 07, 2020
MEI Pharma Reports Fiscal Third-Quarter 2020 Results and Recent Corporate Highlights
Apr 14, 2020
MEI Pharma Appoints Cheryl Cohen, Product Launch and Commercialization Veteran, to its Board of Directors
Apr 14, 2020
MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
Mar 31, 2020
MEI Pharma Announces Fast Track Designation Granted by U.S. FDA for ME-401 For the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma
Feb 06, 2020
MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights
Dec 19, 2019
MEI Pharma Announces Closing of Public Offering of Common Stock
Dec 17, 2019
MEI Pharma Announces Pricing of Public Offering of Common Stock
Dec 16, 2019
MEI Pharma Announces Proposed Public Offering of Common Stock
Nov 12, 2019
MEI Pharma to Present at the Stifel 2019 Healthcare Conference
Nov 07, 2019
MEI Pharma Reports First Quarter Fiscal Year 2020 Results and Operational Highlights
Oct 03, 2019
MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies
Sep 23, 2019
MEI Pharma to Host Investor and Analyst Event on October 4, 2019
Aug 29, 2019
MEI Pharma to Present at the 2019 Wells Fargo Healthcare Conference
Aug 28, 2019
MEI Pharma Reports Fiscal Year 2019 Results and Operational Highlights
Aug 21, 2019
MEI Pharma to Release 2019 Fiscal Year End Financial Results and Provide Corporate Update on August 28, 2019
Jul 03, 2019
MEI Pharma Appoints Longtime Industry Consultant and Executive Tamar Howson to its Board of Directors
Jun 03, 2019
MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study in Patients with Follicular Lymphoma at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 01, 2019
MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2019
MEI Pharma to Present at the Jefferies 2019 Global Healthcare Conference